Standardized Yoga & Meditation Program for Stress Reduction for Adolescents With Irritable Bowel Syndrome
Part of paid clinical trials in Camden, New Jersey.
- Sponsor
- The Cooper Health System
- Study ID
- NCT05719246
- Status
- Recruiting
Conditions
- Anxiety
- Irritable Bowel Syndrome
- Quality of Life
Eligibility Criteria
- Sex
- ALL
- Age
- 12 Years - 21 Years
- Healthy Volunteers
- Accepted
Interventions
- Yoga — BEHAVIORALThe yoga video set that the participants will follow is a brief, at-home, 6-week twice per week Standardized Yoga \& Meditation Program for Stress Reduction (SYMPro-SR) program. The videos feature Sydney Topfer guiding the participants through different yoga poses.
Study Details
Irritable Bowel Syndrome (IBS) is the most common cause of recurrent abdominal pain in children. IBS is a functional gastrointestinal disorder that is linked to motor and sensory physiology, as well as the central nervous system, that presents as abdominal pain with abnormal defecation patterns. This discomfort leads to emotional stress, decreased quality of life, and anxiety. The study proposes that yoga and mindfulness will decrease anxiety and increase quality of life for patients with IBS. The aim of this study is to measure the impact of a brief, at-home, 6-week twice per week Standardized Yoga \& Meditation Program for Stress Reduction program on anxiety, IBS symptoms, and quality of life in children ages 12-21 diagnosed with IBS.
Key Dates
- Start date
- Dec 30, 2020
- Status verified
- Oct 2024
- Primary completion
- Dec 31, 2026
- Completion
- Dec 31, 2026
Study Design
- Enrollment
- 10 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- SUPPORTIVE_CARE
Arms
- Experimental: IBS Patients Doing YogaAll patients will fall under the arm of "IBS Patients Doing Yoga" and will follow the yoga videos that are assigned to them during the study. The participants are their own controls and their symptom changes will be recorded pre- and post-video watching and participation.
Primary Outcome Measure
Pediatric Quality of Life [ Time Frame: Change from Pre intervention to 6 weeks after intervention (at completion of intervention which lasts 6 weeks) ]
Central Contacts
- Alla Kushnir, MD856-342-2265
- Sydney Topfer, BS201-563-5715
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Cooper University Hospital | Camden | New Jersey | 08103 | Sydney Topfer, BS (SUB_INVESTIGATOR) Marisa Wozniak, BS (SUB_INVESTIGATOR) Natalie Morris, BS (SUB_INVESTIGATOR) Katherine Kaminski, BS (SUB_INVESTIGATOR) Alla Kushnir, MD (PRINCIPAL_INVESTIGATOR) Basant Pradhan, MD (SUB_INVESTIGATOR) |
Find similar trials in Camden, NJ
Related Studies
- Study to Explore the Therapeutic Effect of Eluxadoline in Treating Irritable Bowel Syndrome With Diarrhea in ChildrenPHASE2 · Recruiting · AbbVie · Hot Springs, Arkansas
- mHealth Mindfulness With Patients With Serious Illness and Their CaregiversRecruiting · Rutgers, The State University of New Jersey · Livingston, New Jersey
- Behavioral Exposure for Introceptive Tolerance RCTPHASE2 · Recruiting · Rutgers, The State University of New Jersey · East Brunswick, New Jersey
- SilverCloud as a School-Based Intervention for Vulnerable YouthRecruiting · NYU Langone Health · New Brunswick, New Jersey